Long COVID: Neurological Manifestations - an Updated Narrative Review

Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.

Citing Articles

A Step Forward in Long COVID Research: Validating the Post-COVID Cognitive Impairment Scale.

Pour Mohammadi S, Etesamipour R, Mercado Romero F, Pelaez I Eur J Investig Health Psychol Educ. 2024; 14(12):3001-3018.

PMID: 39727505 PMC: 11675825. DOI: 10.3390/ejihpe14120197.

Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, L., in Long COVID and Other Conditions Involving Cognitive Impairment.

Papadopoulou P, Polissidis A, Kythreoti G, Sagnou M, Stefanatou A, Theoharides T Int J Mol Sci. 2024; 25(20).

PMID: 39456822 PMC: 11507169. DOI: 10.3390/ijms252011040.

Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment.

Frank N, Dickinson D, Lovett G, Liu Y, Yu H, Cai J Pharmaceutics. 2024; 16(6).

PMID: 38931912 PMC: 11206978. DOI: 10.3390/pharmaceutics16060791.

References

Crunfli F, Carregari V, Veras F, Silva L, Nogueira M, Antunes A . Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022; 119(35):e2200960119. PMC: 9436354. DOI: 10.1073/pnas.2200960119. View

Rabinovitz B, Jaywant A, Fridman C . Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic. Clin Neuropsychol. 2020; 34(7-8):1453-1479. DOI: 10.1080/13854046.2020.1803408. View

Montplaisir J, Petit D, Quinn M, Ouakki M, Deceuninck G, Desautels A . Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One. 2014; 9(9):e108489. PMC: 4180737. DOI: 10.1371/journal.pone.0108489. View

Lai Y, Liu S, Manachevakul S, Lee T, Kuo C, Bello D . Biomarkers in long COVID-19: A systematic review. Front Med (Lausanne). 2023; 10:1085988. PMC: 9895110. DOI: 10.3389/fmed.2023.1085988. View

Graham E, Clark J, Orban Z, Lim P, Szymanski A, Taylor C . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021; 8(5):1073-1085. PMC: 8108421. DOI: 10.1002/acn3.51350. View

Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A . Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020; 144:110055. PMC: 7320866. DOI: 10.1016/j.mehy.2020.110055. View

Teller N, Chad J, Wong A, Gunraj H, Ji X, Goubran M . Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: Application in COVID-19. Hum Brain Mapp. 2023; 44(10):3998-4010. PMC: 10258529. DOI: 10.1002/hbm.26322. View

Hugon J, Queneau M, Sanchez Ortiz M, Msika E, Farid K, Paquet C . Cognitive decline and brainstem hypometabolism in long COVID: A case series. Brain Behav. 2022; 12(4):e2513. PMC: 9014998. DOI: 10.1002/brb3.2513. View

Peluso M, Sans H, Forman C, Nylander A, Ho H, Lu S . Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm. 2022; 9(5. PMC: 9210548. DOI: 10.1212/NXI.0000000000200003. View

10.

Jafar A, Lasso A, Shorr R, Hutton B, Kilty S . Olfactory recovery following infection with COVID-19: A systematic review. PLoS One. 2021; 16(11):e0259321. PMC: 8577770. DOI: 10.1371/journal.pone.0259321. View

11.

Ferrara F, Zovi A, Masi M, Langella R, Trama U, Boccellino M . Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(7):1583-1589. PMC: 9918819. DOI: 10.1007/s00210-023-02417-5. View

12.

Jaywant A, Vanderlind W, Alexopoulos G, Fridman C, Perlis R, Gunning F . Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021; 46(13):2235-2240. PMC: 7884062. DOI: 10.1038/s41386-021-00978-8. View

13.

Komaroff A, Lipkin W . ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023; 10:1187163. PMC: 10278546. DOI: 10.3389/fmed.2023.1187163. View

14.

Low R, Low R, Akrami A . A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne). 2023; 10:1011936. PMC: 10103649. DOI: 10.3389/fmed.2023.1011936. View

15.

Moura A, Oliveira D, Torres D, Tavares-Junior J, Nobrega P, Braga-Neto P . Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study. BMC Neurol. 2022; 22(1):417. PMC: 9643986. DOI: 10.1186/s12883-022-02940-7. View

16.

Busatto G, de Araujo A, Castaldelli-Maia J, Damiano R, Imamura M, Guedes B . Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol Med. 2022; 52(12):2387-2398. PMC: 9151630. DOI: 10.1017/S0033291722001374. View

17.

Cutler D . The Costs of Long COVID. JAMA Health Forum. 2022; 3(5):e221809. DOI: 10.1001/jamahealthforum.2022.1809. View

18.

Matias-Guiu J, Herrera E, Gonzalez-Nosti M, Krishnan K, Delgado-Alonso C, Diez-Cirarda M . Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach. Psychiatry Res. 2022; 319:115006. DOI: 10.1016/j.psychres.2022.115006. View

19.

Damiano R, Brandao Neto D, Oliveira J, Santos J, Alves J, Guedes B . Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci. 2022; 273(2):325-333. PMC: 9142732. DOI: 10.1007/s00406-022-01427-3. View

20.

Sankowski R, Mader S, Valdes-Ferrer S . Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015; 9:28. PMC: 4313590. DOI: 10.3389/fncel.2015.00028. View